- Home
- PSMT vs LNTH Comparison
PSMT vs LNTH Comparison
Compare PSMT & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSMT
- LNTH
- Stock Information
- Founded
- PSMT 1994
- LNTH 1956
- Country
- PSMT United States
- LNTH United States
- Employees
- PSMT N/A
- LNTH N/A
- Industry
- PSMT Department/Specialty Retail Stores
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- PSMT Consumer Discretionary
- LNTH Health Care
- Exchange
- PSMT Nasdaq
- LNTH Nasdaq
- Market Cap
- PSMT 3.2B
- LNTH 3.6B
- IPO Year
- PSMT 1997
- LNTH 2015
- Fundamental
- Price
- PSMT $107.26
- LNTH $54.86
- Analyst Decision
- PSMT
- LNTH Strong Buy
- Analyst Count
- PSMT 0
- LNTH 6
- Target Price
- PSMT N/A
- LNTH $105.50
- AVG Volume (30 Days)
- PSMT 173.5K
- LNTH 2.6M
- Earning Date
- PSMT 10-29-2025
- LNTH 08-06-2025
- Dividend Yield
- PSMT 1.17%
- LNTH N/A
- EPS Growth
- PSMT 15.87
- LNTH N/A
- EPS
- PSMT 4.75
- LNTH 3.77
- Revenue
- PSMT $5,165,164,000.00
- LNTH $1,520,653,000.00
- Revenue This Year
- PSMT $9.61
- LNTH N/A
- Revenue Next Year
- PSMT $9.58
- LNTH $3.24
- P/E Ratio
- PSMT $22.65
- LNTH $14.55
- Revenue Growth
- PSMT 7.47
- LNTH 5.75
- 52 Week Low
- PSMT $81.25
- LNTH $47.25
- 52 Week High
- PSMT $114.01
- LNTH $118.21
- Technical
- Relative Strength Index (RSI)
- PSMT 45.59
- LNTH 38.69
- Support Level
- PSMT $105.46
- LNTH $55.01
- Resistance Level
- PSMT $110.20
- LNTH $60.14
- Average True Range (ATR)
- PSMT 2.93
- LNTH 2.04
- MACD
- PSMT -0.47
- LNTH 0.75
- Stochastic Oscillator
- PSMT 21.05
- LNTH 57.70
About PSMT PriceSmart Inc.
Pricesmart Inc is principally engaged in operating U.S.-style membership shopping warehouse clubs that offer consumer goods at low prices. The company is headquartered in San Diego, California, United States, and operates stores in the Caribbean, Costa Rica, Panama, and other regions. The company's revenue consists of net warehouse club sales from merchandise sales, membership income from annual membership fees, export sales, and other income. Its operations consist of four reportable segments; Central America, the Caribbean, Colombia, and the United States. A majority of the company's revenue is derived from Central America.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.